524400 — Ishita Drugs And Industries Cashflow Statement
0.000.00%
- IN₹216.02m
- IN₹129.05m
- IN₹149.97m
- 77
- 48
- 54
- 66
Annual cashflow statement for Ishita Drugs And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10.5 | 10.4 | 7.79 | 9.87 | 11.6 |
| Depreciation | |||||
| Non-Cash Items | -2.82 | -0.816 | -1.47 | -1.9 | -2.64 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -15.9 | 19.9 | -36.6 | 12.1 | -46.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.75 | 30.8 | -29 | 21.2 | -36.4 |
| Capital Expenditures | -0.049 | -0.185 | -1.34 | -0.268 | -1.84 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 24.6 | -9.16 | 7.28 | 1.57 | -4.82 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 24.5 | -9.34 | 5.94 | 1.3 | -6.66 |
| Financing Cash Flow Items | 0.087 | 0.436 | 0.893 | 0.909 | 2.12 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.37 | 0.017 | 10.5 | -8.7 | 43.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.4 | 21.4 | -12.5 | 13.8 | 0.24 |